Contact this trialFirst, we need to learn more about you.
Radioisotope Therapy
Lutathera for Meningioma
Recruiting1 awardPhase 2
Cleveland, Ohio
This trial will test whether Lutathera is effective in treating meningioma. Lutathera will be given intravenously every 8 weeks for 4 doses, and PET-MRI scans will be done before treatment and 6 months after the start of treatment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.